ArticleOncogene2014
LKB1 loss by alteration of the NKX2-1/p53 pathway promotes tumor malignancy and predicts poor survival and relapse in lung adenocarcinomas.
L-H Tsai et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
29 papers cite it
this paperpooled itcites it